Fresenius Medical Care has announced the launch of 6008 CAREsystem in China, consisting of the hemodialysis system 6008 and the associated 6008 CAREset, at 2023 Annual Conference of the Chinese Society of Nephrology in Xiamen City, Fujian Province.

Guests at the launch ceremony included

  • Prof. Hongli Lin from the First Hospital of Dalian Medical University;
  • Prof. Minghui Zhao from the First Hospital of Peking University;
  • Prof. Xiaonong Chen from Ruijin Hospital of Shanghai Jiaotong University School of Medicine;
  • Gunther Klotz, Head of Global Market Strategic Planning for Chronic Dialysis Medical Technologies at Fresenius Medical Care;
  • René Bauer, Director of Global Product Management for High-End Therapies at Fresenius Medical Care;
  • Alan Chen (Yugang), President of Fresenius Medical Care China.
Alan Chen Yugang, President of Fresenius Medical Care China
“As China shifts to value-based care, we need to harness the power of scientific and technological innovation to provide solutions that help hospital clinical departments operate efficiently and help patients receive individualized treatment to achieve a better quality of life. Fresenius Medical Care is committed to creating a better future for Chinese kidney patients by building the Fresenius Intelligent Dialysis Portfolios.”

Providing Chinese patients with chronic kidney disease with high-quality haemodialysis filtration therapy, while effectively reducing the complexity of the treatment process and providing efficient haemodialysis treatment solutions for the healthcare community, is a constant focus for Fresenius Medical Care.

en_GBEnglish (UK)